TY - JOUR
T1 - Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives
AU - Habala, Ladislav
AU - Galanski, Mathea Sophia
AU - Yasemi, Afshin
AU - Nazarov, Alexey
AU - Keyserlingk, Nikolai Graf v.
AU - Keppler, Bernhard
N1 - DOI: 10.1016/j.ejmech.2005.06.003
Coden: EJMCA
Affiliations: Institute of Inorganic Chemistry - Bioinorganic, Environmental- and Radiochemistry, University of Vienna, Waehringerstr. 42, A-1090 Vienna, Austria; Faustus Forschungs Compagnie Translational Cancer Research GmbH, Grimmaische Str. 2 - 4 / Aufgang B, D-04109 Leipzig, Germany
Adressen: Galanski, M.; Institute of Inorganic Chemistry - Bioinorganic, Environmental- and Radiochemistry; University of Vienna; Waehringerstr. 42 A-1090 Vienna, Austria; email: [email protected]
Source-File: ChemieErgScopus.csv
Import aus Scopus: 2-s2.0-26844514573
Importdatum: 09.01.2007 14:08:00
12.02.2008: Datenanforderung 2112 (Import Sachbearbeiter)
09.02.2010: Datenanforderung UNIVIS-DATEN-DAT.RA-2 (Import Sachbearbeiter)
PY - 2005
Y1 - 2005
N2 - In order to improve the pharmacological profile of the anticancer drug oxaliplatin, (trans-R,R-cyclohexane-1,2-diamine)oxalatoplatinum(II), and to explore activity-structure relationships, new mono- and dialkyl substituted oxaliplatin analogues have been synthesized. Following a new synthetic strategy, racemates with a defined stereochemistry at carbon atoms 1, 2, 4, and 5 of the cyclohexane ring could be prepared, which are the bases for reliable structure-activity relationships and the following enantiomer resolution. The cytotoxicity was evaluated in nine tumor cell lines, indicating that bulky substituents have a negative influence on the cytotoxic potency of the oxaliplatin derivatives. With respect to the antiproliferative properties, the 4-methyl-, cis-4,5-dimethyl-, and especially the 4,4-dimethyl-trans-cyclohexane- 1,2-diamine(oxalato)platinum(II) complexes are the most promising candidates to be further evaluated. Œ 2005 Elsevier SAS. All rights reserved.
AB - In order to improve the pharmacological profile of the anticancer drug oxaliplatin, (trans-R,R-cyclohexane-1,2-diamine)oxalatoplatinum(II), and to explore activity-structure relationships, new mono- and dialkyl substituted oxaliplatin analogues have been synthesized. Following a new synthetic strategy, racemates with a defined stereochemistry at carbon atoms 1, 2, 4, and 5 of the cyclohexane ring could be prepared, which are the bases for reliable structure-activity relationships and the following enantiomer resolution. The cytotoxicity was evaluated in nine tumor cell lines, indicating that bulky substituents have a negative influence on the cytotoxic potency of the oxaliplatin derivatives. With respect to the antiproliferative properties, the 4-methyl-, cis-4,5-dimethyl-, and especially the 4,4-dimethyl-trans-cyclohexane- 1,2-diamine(oxalato)platinum(II) complexes are the most promising candidates to be further evaluated. Œ 2005 Elsevier SAS. All rights reserved.
M3 - Article
SN - 0223-5234
VL - 40
SP - 1149
EP - 1155
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
IS - 11
ER -